Ignite Creation Date:
2024-05-06 @ 2:21 PM
Last Modification Date:
2024-10-26 @ 1:30 PM
Study NCT ID:
NCT04298567
Status:
COMPLETED
Last Update Posted:
2024-06-28
First Post:
2020-02-19
Brief Title:
Study to Learn More About the Safety and Effectiveness of Rivaroxaban Xarelto When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart CAD andor With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms Symptomatic PAD
Sponsor:
Bayer
Organization:
Bayer
Organization Data
Organization:
Bayer
Class:
INDUSTRY
Study ID:
21269
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bayer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None